News
BSSP
0.0001
NaN%
--
Weekly Report: what happened at BSSP last week (0504-0508)?
Weekly Report · 5d ago
Weekly Report: what happened at BSSP last week (0427-0501)?
Weekly Report · 05/04 09:59
Weekly Report: what happened at BSSP last week (0420-0424)?
Weekly Report · 04/27 10:00
Weekly Report: what happened at BSSP last week (0413-0417)?
Weekly Report · 04/20 09:57
Weekly Report: what happened at BSSP last week (0406-0410)?
Weekly Report · 04/13 10:00
Weekly Report: what happened at BSSP last week (0330-0403)?
Weekly Report · 04/06 10:00
Weekly Report: what happened at BSSP last week (0323-0327)?
Weekly Report · 03/30 10:01
Weekly Report: what happened at BSSP last week (0316-0320)?
Weekly Report · 03/23 09:57
Weekly Report: what happened at BSSP last week (0309-0313)?
Weekly Report · 03/16 09:57
Weekly Report: what happened at BSSP last week (0302-0306)?
Weekly Report · 03/09 09:58
Weekly Report: what happened at BSSP last week (0223-0227)?
Weekly Report · 03/02 09:57
Weekly Report: what happened at BSSP last week (0216-0220)?
Weekly Report · 02/23 09:57
Weekly Report: what happened at BSSP last week (0209-0213)?
Weekly Report · 02/16 09:57
Weekly Report: what happened at BSSP last week (0202-0206)?
Weekly Report · 02/09 09:58
Weekly Report: what happened at BSSP last week (0126-0130)?
Weekly Report · 02/02 09:58
Weekly Report: what happened at BSSP last week (0119-0123)?
Weekly Report · 01/26 09:58
Weekly Report: what happened at BSSP last week (0112-0116)?
Weekly Report · 01/19 10:02
Weekly Report: what happened at BSSP last week (0105-0109)?
Weekly Report · 01/12 10:01
Weekly Report: what happened at BSSP last week (1229-0102)?
Weekly Report · 01/05 09:57
Weekly Report: what happened at BSSP last week (1222-1226)?
Weekly Report · 12/29/2025 09:57
More
Webull provides a variety of real-time BSSP stock news. You can receive the latest news about Bassline Productions Inc through multiple platforms. This information may help you make smarter investment decisions.
About BSSP
Baseline Productions, Inc., formerly Cantech Holding, Inc., is a development-stage immunotherapeutic-based technology company. The Company is focused on commercialization of its proteins for the treatment of cancer and various infectious diseases. Its Irreversible Pepsin Fraction (IPF) is a therapeutic platform technology that can be used to facilitate a range of applications. IPF turns on the immune system to fight autoimmune diseases. IPF binds to thymus (T)-cells and turns on T helper cell type 1 (Th1) immune system responses that kill infected cells. The Company's lead compound is a suspension of IPF, which is indicated for the treatment of autoimmune diseases, such as cancer, cirrhosis and Hepatitis C. The Company's product, IMMUNE-THERAPEUTIC PROTEIN (ITP), is a therapeutic protein isolated from porsine pepsin, which is irreversible, modified, and fractionate to the sequence IPF.